Naveena, T. (2017). Empagliflozin: a wonder drug in preventing diabetic nephropathy and cardiovascular effects. International Journal of Basic & Clinical Pharmacology, 5(5), 1704–1707. https://doi.org/10.18203/2319-2003.ijbcp20163202